[1]
林京香, 王佑春, 张华远, 2000: Study on Indeterminate HBsAg Samples, Virologica Sinica, 15, 8-10.
[2]
魏战勇, 崔保安, 黄克和, 王学斌, 金喜新, 张龙现, 2005: Inhibitory Effects of Nitric oxide on the Porcine Parvovirus infection in vitro, Virologica Sinica, 20, 33-36.
[3]
Ran Xiao, Shan Li, Qian Cao, Xiuling Wang, Qiujin Yan, Xiaoning Tu, Ying Zhu, Fan Zhu, 2017: Human endogenous retrovirus W env increases nitric oxide production and enhances the migration ability of microglia by regulating the expression of inducible nitric oxide synthase, Virologica Sinica, 32, 216-225. doi: 10.1007/s12250-017-3997-4
[4]
张润高, 黄志戎, 1989: The “Tail” Phenomenon on Surface of HBsAg Particles, Virologica Sinica, 4, 113-.
[5]
王佑春, 李河民, 胡宗汉, 1992: Analysis of peptides of HBsAg and the Epitopes of "a" Determinant by Monoclonal Antihody, Virologica Sinica, 7, 48-.
[6]
彭宣宪, 方亮, 谢天益, 李兆瑞, 李建生, 1990: Detection and Significance of Circulating HBsAg/IgA Immune Complexes in Patients with Hepatitis B, Virologica Sinica, 5, 24-.
[7]
宋宏彬, 毛春生, 陈薇, 杜勇, 徐德忠, 王海涛, 1999: Construction，Expression and Folding of dsFv Mutated Gene of H um an Antibody to HBsAg, Virologica Sinica, 14, 42-47.
[8]
Minghui Li, Lu Zhang, Yao Lu, Qiqi Chen, Huihui Lu, Fangfang Sun, Zhan Zeng, Gang Wan, Linqing Zhao, Yao Xie, 2021: Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a, Virologica Sinica, 36, 311-320. doi: 10.1007/s12250-020-00290-7
[9]
Jia LIU, Yan YANG, Bin HU, Zhi-yong MA, Hong-ping HUANG, Yuan YU, Shen-pei LIU, Meng-ji LU, Dong-liang YANG, 2010: Development of HBsAg-Binding Aptamers that bind HepG2.2.15 cells via HBV surface antigen, Virologica Sinica, 25, 27-35. doi: 10.1007/s12250-010-3091-7
[10]
汤华, 任中原, 张灏, 宗建超, 倪爱国, 刘福森, 1993: Studies on Inhibition of Antisense Phosphorothioate Oligodeoxynucleotides on Expression of HBsAg and HBeAg in Cell Culture System, Virologica Sinica, 8, 327-331.
[11]
田拥军, 覃莉, 张正茂, 李磊, 雷延昌, 喻植群, 赵西平, 杨东亮*, 2005: Study on a Transgenic Cell Line Stable Expression Gly145Arg Mutation HBsAg, Virologica Sinica, 20, 574-577.
[12]
谭维国, 李法卿, 吴玉强, 吴德福, 龚希平, 1994: Detection of HBsAgHBeAg and HBV DNA in Urinary cells of Patients with Hepatitis B an d HBsAg Carriers, Virologica Sinica, 9, 100-103.
[13]
Minghui Li, Fangfang Sun, Xiaoyue Bi, Yanjie Lin, Liu Yang, Yao Lu, Lu Zhang, Gang Wan, Wei Yi, Linqing Zhao, Yao Xie, 2022: Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients, Virologica Sinica, 37, 390-397. doi: 10.1016/j.virs.2022.03.001
[14]
Wen Deng, Hongxiao Hao, Ziyu Zhang, Xinxin Li, Weihua Cao, Yaqin Zhang, Shiyu Wang, Zixuan Gao, Linmei Yao, Shuojie Wang, Xin Wei, Wei Yi, Linqing Zhao, Yao Xie, Minghui Li, 2025: Clinical outcomes after HBsAg clearance in chronic hepatitis B patients treated with Peg-IFN α: A study with an 11- to 173-month follow-up, Virologica Sinica, 40, 579-586. doi: 10.1016/j.virs.2025.06.008
[15]
Yang-fei XIANG, Huai-qiang JU, Shen LI, Ying-jun ZHANG, Chong-ren YANG, Yi-fei WANG, 2010: Effects of 1, 2, 4, 6-tetra-O-galloyl-β-D-glucose from P. emblica on HBsAg and HBeAg Secretion in HepG2.2.15 Cell Culture^*, Virologica Sinica, 25, 375-380. doi: 10.1007/s12250-010-3144-y